σ₂ Receptor and Its Role in Cancer with Focus on a MultiTarget Directed Ligand (MTDL) Approach

by Francesca Serena Abatematteo, Mauro Niso, Enza Lacivita, Carmen Abate
Published 2021-06-01

Multi-Target Directed Ligands (MTDLs) Binding the σ₁ Receptor as Promising Therapeutics: State of the Art and Perspectives

by Francesca Serena Abatematteo, Mauro Niso, Marialessandra Contino, Marcello Leopoldo, Carmen Abate
Published 2021-06-01

PB28, the Sigma-1 and Sigma-2 Receptors Modulator With Potent Anti–SARS-CoV-2 Activity: A Review About Its Pharmacological Properties and Structure Affinity Relationships

by Carmen Abate, Mauro Niso, Francesca Serena Abatematteo, Marialessandra Contino, Nicola Antonio Colabufo, Francesco Berardi
Published 2020-12-01

MRP1-Collateral Sensitizers as a Novel Therapeutic Approach in Resistant Cancer Therapy: An In Vitro and In Vivo Study in Lung Resistant Tumor

by Chiara Riganti, Roberta Giampietro, Joanna Kopecka, Costanzo Costamagna, Francesca Serena Abatematteo, Marialessandra Contino, Carmen Abate
Published 2020-05-01

NO1, a New Sigma 2 Receptor/TMEM97 Fluorescent Ligand, Downregulates SOCE and Promotes Apoptosis in the Triple Negative Breast Cancer Cell Lines

by Carlos Cantonero, Pedro Javier Camello, Carmen Abate, Francesco Berardi, Gines Maria Salido, Juan Antonio Rosado, Pedro C. Redondo
Published 2020-01-01

Sigma-2 receptor/TMEM97 agonist PB221 as an alternative drug for brain tumor

by Chia-Chi Liu, Ching-Fang Yu, Shu-Chi Wang, Hsueh-Yin Li, Chiu-Min Lin, Hsia-Han Wang, Carmen Abate, Chi-Shiun Chiang
Published 2019-05-01